{
  "main_header": {
    "sid": 1002724,
    "name": "Parmax Pharma",
    "stock_name": "Parmax Pharma",
    "full_name": "Parmax Pharma Ltd",
    "name_url": "stocks-analysis/parmax-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "68.02",
    "chg": 1.33,
    "chgp": "1.99%",
    "dir": 1,
    "prev_price": "66.69",
    "mcapval": "25.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 540359,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE240T01014",
    "curr_date": "Jun 18",
    "curr_time": "",
    "bse_nse_vol": "1.26 k",
    "exc_status": "Active",
    "traded_date": "Jun 18, 2026",
    "traded_date_str": "2026 06 18",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/parmax-pharma-1002724-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Parmax Pharma Ltd Falls to 52-Week Low of Rs 22.6 as Sell-Off Deepens",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/parmax-pharma-ltd-stock-falls-to-52-week-low-of-rs226-3915864",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/ParmaxPharmaLtd_priceRelatedfactors_3915864.png",
        "date": "2026-03-25 10:02:56",
        "description": ""
      }
    ],
    "total": 4,
    "sid": "1002724",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/parmax-pharma-1002724"
  },
  "announcements": [
    {
      "caption": "Detailed Public Statement",
      "datetime": "15-Jun-2026",
      "details": "Fedex Securities Pvt Ltd (Manager to the Offer) has submitted to BSE a copy of Detailed Public Statement in terms of Regulations 3(1) and 4 read with Regulations 13(4) 14 (3) and 15(2) and other applicable Regulations of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations 2011 as amended (SEBI (SAST) Regulations 2011) to the Publicshareholders of Parmax Pharma Limited (Target Company).",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "11-Jun-2026",
      "details": "Regarding Notice of EGM and E-voting",
      "source": "BSE"
    },
    {
      "caption": "Open Offer",
      "datetime": "09-Jun-2026",
      "details": "Fedex Securities Pvt Ltd (Manager to the Offer) has submitted to BSE a copy of Public Announcement under Regulation 3(1) And Regulation 4 Read with Regulation 13 Regulation 14 And Regulation 15(1) of the Securities and Exchange Board of India (Substantial Acquisition Of Shares And Takeovers) Regulations 2011 And Subsequent Amendments thereto for the Attention of the Public Shareholders of Parmax Pharma Limited (Target Company).",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Parmax Pharma Ltd Falls to 52-Week Low of Rs 22.6 as Sell-Off Deepens

2026-03-25 10:02:56

Read More

View All News